Thus, when anti-CD3 + IL-2 stimulation was used, the Treg cells of the RA patients showed a higher ability to produce anti-inflammatory cytokines and were characterized by greater CCR4 expression than those from the HDs, which may indicate their activated status in patients with RA. The gene discussed is CCR4; the disease is rheumatoid arthritis.